Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Andre C Kalil; Aneesh K Mehta; Thomas F Patterson; Nathaniel Erdmann; Carlos A Gomez; Mamta K Jain; Cameron R Wolfe; Guillermo M Ruiz-Palacios; Susan Kline; Justino Regalado Pineda

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Andre C Kalil, Aneesh K Mehta, Thomas F Patterson, Nathaniel Erdmann, Carlos A Gomez, Mamta K Jain, Cameron R Wolfe, Guillermo M Ruiz-Palacios, Susan Kline, Justino Regalado Pineda

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1365-1376
Number of pages	12
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	12
State	Published - 2021
Externally published	Yes

Cite this

Kalil, A. C., Mehta, A. K., Patterson, T. F., Erdmann, N., Gomez, C. A., Jain, M. K., Wolfe, C. R., Ruiz-Palacios, G. M., Kline, S., & Pineda, J. R. (2021). Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine, 9(12), 1365-1376.

@article{0a88813af951482c881a18c1b37f8db6,

title = "Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial",

author = "Kalil, {Andre C} and Mehta, {Aneesh K} and Patterson, {Thomas F} and Nathaniel Erdmann and Gomez, {Carlos A} and Jain, {Mamta K} and Wolfe, {Cameron R} and Ruiz-Palacios, {Guillermo M} and Susan Kline and Pineda, {Justino Regalado}",

year = "2021",

language = "English",

volume = "9",

pages = "1365--1376",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier",

number = "12",

}

Kalil, AC, Mehta, AK, Patterson, TF, Erdmann, N, Gomez, CA, Jain, MK, Wolfe, CR, Ruiz-Palacios, GM, Kline, S & Pineda, JR 2021, 'Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial', The Lancet Respiratory Medicine, vol. 9, no. 12, pp. 1365-1376.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial. / Kalil, Andre C; Mehta, Aneesh K; Patterson, Thomas F et al.
In: The Lancet Respiratory Medicine, Vol. 9, No. 12, 2021, p. 1365-1376.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

AU - Kalil, Andre C

AU - Mehta, Aneesh K

AU - Patterson, Thomas F

AU - Erdmann, Nathaniel

AU - Gomez, Carlos A

AU - Jain, Mamta K

AU - Wolfe, Cameron R

AU - Ruiz-Palacios, Guillermo M

AU - Kline, Susan

AU - Pineda, Justino Regalado

PY - 2021

Y1 - 2021

M3 - Article

SN - 2213-2600

VL - 9

SP - 1365

EP - 1376

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 12

ER -

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Fingerprint

Cite this